Intermediate-risk childhood acute lymphoblastic leukemias: amsacrine + cytosine arabinoside versus intermediate-dose methotrexate for consolidation, and 6-mercaptopurine + methotrexate + vincristine versus monthly pulses for maintenance.
作者信息
Schaison G, Leverger G, Bancillon A, Marty M, Olive D, Cornu G, Griscelli C, Lemerle S, Harousseau J L, Bonnet M
出版信息
Haematol Blood Transfus. 1987;30:461-5. doi: 10.1007/978-3-642-71213-5_81.
PMID:3305213
Abstract
摘要
Zotero 插件